SA Pharmaceutical Journal - latest Issue
Volume 83, Issue 9, 2016
Author Sarel MalanSource: SA Pharmaceutical Journal 83, pp 6 –7 (2016)More Less
Author Lynda SteynSource: SA Pharmaceutical Journal 83, pp 8 –10 (2016)More Less
Triamcinolone acetonide is a synthetic corticosteroid and about 8 times more potent than prednisone. The metered-dose nasal spray is a thixotropic formulation, containing triamcinolone acetonide suspended in a water-based medium. Each delivered dose of spray contains 55 micrograms (mcg) of triamcinolone acetonide.
Source: SA Pharmaceutical Journal 83, pp 34 –40 (2016)More Less
Rheumatoid arthritis is an autoimmune disease that does not only affect the small joints, but also presents with extra-articular manifestations e.g. anaemia, cardiovascular diseases, depression etc., leading to increased morbidity and mortality. Pharmacists, as part of the healthcare team, should take cognisance of this chronic, debilitating condition and keep up to date with the latest treatment strategies. Early diagnosis of rheumatoid arthritis is imperative and treatment should be individualised and appropriate as it improves the prognosis. The 2013 South African algorithm for the treatment of rheumatoid arthritis recommends the use of disease-modifying anti-rheumatic medicine as first-line therapy. The choice of treatment depends on the side-effect profile, patient preference for route of administration, disease characteristics, and cost. There is no cure for rheumatoid arthritis but articular damage can be prevented or at least delayed.
Source: SA Pharmaceutical Journal 83, pp 41 –47 (2016)More Less
The world is on the brink of a post antibiotic era and antibiotic resistance is no longer a prediction for the future; it is happening right now, across the world, and has the potential to put public health efforts into disarray. Despite the wealth of programmes and information, South Africa is not exempt from the threat of increasing antimicrobial resistance. An overview of the persisting issue of antimicrobial resistance, the current trends in antimicrobial stewardship and strategies for rational antibiotic use is provided. Specific emphasis is placed on the role of the pharmacist in containing antimicrobial resistance across the different practice settings, and working in collaboration with other healthcare professionals.
Source: SA Pharmaceutical Journal 83, pp 48 –56 (2016)More Less
Alzheimer's disease is a degenerative disease of the brain, the most common cause of dementia in the geriatric population, and a major cause of death. Alzheimer's disease places a heavy burden on families, communities and society, in terms of care and costs. This is compounded by the fact that populations across the world are having a longer life expectancy. An overview of Alzheimer's as a disease state and its pharmacological and non-pharmacological management is provided in the paper. Caring for the person diagnosed with Alzheimer's may be taxing and thus caring for the carer is also described.
Author Joggie HattinghSource: SA Pharmaceutical Journal 83, pp 57 –59 (2016)More Less
76th FIP World Congress of Pharmacy and Pharmaceutical Sciences 2016 - Buenos Aires Argentina 28 August to 1 September 2016
Firstly allow me to express my gratitude towards Western Cape Government: Health for allowing me to attend this very important conference and towards SAAHIP who delegated and funded me.
Author Andy GraySource: SA Pharmaceutical Journal 83, pp 60 –61 (2016)More Less
One of the longest-running series in the American Journal of Health-System Pharmacy is that reporting on the annual ASHP surveys of hospital pharmacies conducted in the United States. Each report deals with a specific area of practice, as the entire gamut of questions is now too extensive to allow reporting in a single publication. The most recent version, published in September 2016, deals with the issues of patient monitoring and education.
International Collaboration 29th Pharmintercom report : Boston Conference in the USA : pharmaceutical practitionerAuthor Kobus Le RouxSource: SA Pharmaceutical Journal 83, pp 65 –66 (2016)More Less
The Pharmintercom meeting was attended by the seven English speaking countries namely Australia, Canada, Ireland, New Zealand, South Africa, United Kingdom and hosted by the United States of America in the historic city of Boston. The attendees were the Presidents and CEOs of the various country associations, and I must admit that I was delighted to see many younger faces around the table. The agenda is determined by the hosting country, but during the presentation of the country reports any burning issues will be addressed. In many instances members can suggest a solution to common problems. The meeting is very open, but a member may discuss confidential issues to assist other member countries. The value of sharing information and projects is immense to everybody attending.
Author Francois Van der WaltSource: SA Pharmaceutical Journal 83 (2016)More Less
Listening to the topics discussed during the last PSSA national exco meeting held in Pretoria during August, it suddenly dawned upon me that we often pick a fight just for the sake of doing something. I was looking at my fellow pharmacists, wondering what spurred them on in life. Is it being a good pharmacist, is it being an asset to the community, is it being there where the action is or is it a genuine calling in life that spurs them on?